For most physical therapy practice owners, the prospect of staff learning about a potential sale is the single most anxiety-inducing aspect of the process. The concern is legitimate: employees who learn the practice might be sold often begin looking for other jobs, patient care can be disrupted, and buyer confidence in the stability of the team can erode — all before a deal is even close to closing.

A professionally managed sale process is built around confidentiality at every stage. Here is how that actually works in practice.

The Anonymous Teaser: Your Practice Has No Name

The first document sent to any potential buyer is an anonymous teaser — a one to two page summary of your practice's financial metrics, location count, service lines, and rough geographic region. The language is deliberately vague: "Northeast multi-site outpatient rehab group" rather than any identifying information. Your practice name, exact location, or any detail that could identify you is never included.

Buyers who are interested respond to the teaser and sign a Non-Disclosure Agreement before receiving any additional information. Only after the NDA is executed does the buyer learn the name of your practice.

NDAs Are Not Optional

Every buyer in a Mihama process signs a legally binding NDA before accessing any identifying information about your practice. The NDA prohibits the buyer from disclosing the existence of a potential sale to anyone outside their direct deal team — including their portfolio company operators in your market — until a deal is closed.

In practice, this means that even buyers who are competitors in your local market receive information only after committing in writing not to use that information in ways that could harm you. We also maintain a curated buyer list that you review and approve before outreach begins, so you control who knows your practice is on the market.

Management Calls: Structured to Protect You

After reviewing the data room, interested buyers typically request a call with ownership — the "management call." These calls are framed as introductory strategic conversations, not sale negotiations. They are scheduled at times and through channels that don't raise flags for staff observing your calendar.

The content of management calls typically covers your growth strategy, the competitive dynamics of your region, your clinical team structure, and your vision for the practice going forward. These are legitimate business conversations that don't require any reference to a transaction. Most sellers find management calls to be one of the more enjoyable parts of the process — they are fundamentally conversations about the business you've built.

Site Visits: After Hours Only

Some buyers request in-person site visits before submitting their LOI. In a Mihama process, site visits are always conducted after hours — typically in the early evening after your last patient has left and before your opening the next morning. No staff are present, and the visit is coordinated quietly through ownership.

The buyer tours your locations, reviews the physical setup, and usually sits down for a meal with you to discuss the practice more informally. This is one of the most valuable steps in the process for buyers — seeing the physical environment, meeting ownership in person, and assessing cultural fit — and it can be done completely without your team's knowledge.

Common question: "What if a buyer or their staff already knows people at my practice?" This is why your buyer list review matters. You have the right to exclude any buyer whose existing presence in your market creates a specific confidentiality risk. Your advisor should know which buyers have employees, partners, or connections in your area and flag these before outreach begins.

Due Diligence: Remote and Centralized

Once an LOI is signed and the process moves into due diligence, data requests are handled entirely between ownership and the buyer's deal team — never routed through your clinical or administrative staff. Financial records, HR documents, and compliance materials are provided through a secure digital data room that staff have no access to or awareness of.

The due diligence period is when confidentiality discipline is most important. Deals that leak during diligence face real consequences: staff turnover, patient anxiety, and in some cases, referral source disruption. Maintaining a consistent operational presence during this period — continuing to hire, continuing normal communications with staff, and maintaining your usual patient flow — is both operationally important and signals to the buyer that the business is stable.

When Do You Tell Your Staff?

In a well-managed process, staff are informed only at or very shortly before closing — when the deal is fully secure and the terms of their employment going forward are defined. At this point, you can have a planned, positive conversation about the transition: who the new partner is, what will and won't change, and what the acquisition means for employee benefits and growth opportunities.

Buyers are generally motivated to have this conversation go well. They've spent significant resources acquiring your team alongside your practice. A well-handled staff announcement — framed around growth, stability, and expanded resources — typically generates far less anxiety than a premature informal disclosure ever would.

Ready to See What Your Practice Is Worth?

Get a confidential, no-obligation conversation with Mihama Acquisitions. We've closed 250+ clinics across 46 states.

Request a Confidential Consultation